Vistin Pharma ASA: Invitation to Q1 2023 conference call

20 Apr 2023 11:00 CEST

Oslo, Norway, 20 April 2023

Vistin Pharma ASA will release its first quarter 2023 results on Thursday 27(th)
of April 2023. Vistin Pharma will host a conference call for all shareholders
and interested parties at the same day: Thursday 27(th) of April at 08:30 CET.
There will be a Q&A session following the management discussion.

The conference call will be held in English.

The first quarter conference call will be available via web and audio through
the following access points:

Webcast:

https://edge.media-server.com/mmc/p/esnqd8k9
(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-
server.com%2Fmmc%2Fp%2Fesnqd8k9&data=05%7C01%7CAlexander.Karlsen%40vistin.com%7C
e1282fd245eb4cfda0c808db26cf9f51%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63
8146445423803497%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJ
BTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=T9eI3Bw2LaVlhTp3jfALgSxf%2FVbY
LMRPGjyScLcQXGQ%3D&reserved=0)

Telephone conference (online registration):

https://register.vevent.com/register/BI27373abc81d0427486bb885a935c342c


*****


For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.

More information:
Access the news on Oslo Bors NewsWeb site